Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGOBSERVATIONAL

Low Intraocular Pressure Cataract Surgery With Zeiss Quatera in Glaucoma Patients

Low Intraocular Pressure Cataract Surgery With Zeiss Quatera in Glaucoma Patients. Prospective, Investigator Initiated and Observational Case Series

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

You were selected to participate in this observational study because you suffer from glaucoma and cataracts. For the cataract you will have cataract surgery. This study will not affect your treatment, it will only collect data on what is performed before, during and after the procedure. The aim of this data collection is to demonstrate the safety of a new generation of cataract surgical devices in patients who also suffer from glaucoma. They are glaucoma patients who have an increased sensitivity to eye pressure increases both during and after surgery. The new surgical device makes it possible to safely perform cataract surgery under low pressures. This could, at least theoretically, provide an advantage for patients who also suffer from glaucoma.

Who May Be Eligible (Plain English)

Who May Qualify: - Patients diagnosed with glaucoma that are diagnosed with age-related cataract Who Should NOT Join This Trial: - Unwilling to sign willing to sign a consent form - Functionally monophtalmic patient - Endothelial dystrophy - Active uveitis - Known corticosteroid responder - Presence of uncontrolled systemic disease Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Patients diagnosed with glaucoma that are diagnosed with age-related cataract Exclusion Criteria: * Unwilling to sign informed consent * Functionally monophtalmic patient * Endothelial dystrophy * Active uveitis * Known corticosteroid responder * Presence of uncontrolled systemic disease

Locations (1)

Visionair Oogzorg
Geel, Belgium